U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
A Report from ASCO 2007 Adjuvant Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical Research.
How should efficacy of new adjuvant therapies be evaluated in colorectal cancer? Marc Buyse, ScD IDDI, Brussels, Belgium Based on Daniel Sargent’s talks.
